1095 Pharmacogenomic analysis of the triplet combination of gemcitabine, oxaliplatin and cetuximab as salvage therapy for metastatic colorectal cancer (mCRC) patients

Autor:	Jesús García-Foncillas, Eva Bandrés, N. Bitarte, M. Ponz, J.A. Diaz-Gonzalez, Javier Rodríguez, R. N. Zarate, Natalia Ramírez, A. Chopitea, A. Hernandez
Rok vydání:	2009
Předmět:	Oncology Cancer Research medicine.medical_specialty Gemcitabine/oxaliplatin Cetuximab business.industry Colorectal cancer Pharmacogenomic Analysis Salvage therapy medicine.disease Internal medicine Medicine business medicine.drug
Zdroj:	European Journal of Cancer Supplements. 7:113
ISSN:	1359-6349
DOI:	10.1016/s1359-6349(09)70388-x
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::723429cd4bd491784cc77aa284ec6fdf https://doi.org/10.1016/s1359-6349(09)70388-x Zobrazit plný text záznamu Full Text from ScienceDirect